These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12627800)

  • 21. Amphotericin B in children with malignant disease: a comparison of the toxicities and pharmacokinetics of amphotericin B administered in dextrose versus lipid emulsion.
    Nath CE; Shaw PJ; Gunning R; McLachlan AJ; Earl JW
    Antimicrob Agents Chemother; 1999 Jun; 43(6):1417-23. PubMed ID: 10348763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disposition of aerosolized liposomal amphotericin B.
    Lambros MP; Bourne DW; Abbas SA; Johnson DL
    J Pharm Sci; 1997 Sep; 86(9):1066-9. PubMed ID: 9294824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antileishmanial activity, pharmacokinetics and tissue distribution studies of mannose-grafted amphotericin B lipid nanospheres.
    Veerareddy PR; Vobalaboina V; Ali N
    J Drug Target; 2009 Feb; 17(2):140-7. PubMed ID: 19089691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of murine candidosis and cryptococcosis with a unilamellar liposomal amphotericin B formulation (AmBisome).
    Adler-Moore JP; Chiang SM; Satorius A; Guerra D; McAndrews B; McManus EJ; Proffitt RT
    J Antimicrob Chemother; 1991 Oct; 28 Suppl B():63-71. PubMed ID: 1778893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel delivery system for amphotericin B with lipid nano-sphere (LNS).
    Fukui H; Koike T; Saheki A; Sonoke S; Seki J
    Int J Pharm; 2003 Oct; 265(1-2):37-45. PubMed ID: 14522116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of liposomal amphotericin B (AmBisome) versus other lipid-based formulations.
    Heinemann V; Kähny B; Debus A; Wachholz K; Jehn U
    Bone Marrow Transplant; 1994; 14 Suppl 5():S8-9. PubMed ID: 7703929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of alternative dosing regimens of poly-aggregated amphotericin B.
    Espada R; Valdespina S; Molero G; Dea MA; Ballesteros MP; Torrado JJ
    Int J Antimicrob Agents; 2008 Jul; 32(1):55-61. PubMed ID: 18534826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel biodegradable poly(gamma-glutamic acid)-amphotericin B complexes show promise as improved amphotericin B formulations.
    Dinh T; Zia Q; Zubair S; Stapleton P; Singh R; Owais M; Somavarapu S
    Nanomedicine; 2017 Jul; 13(5):1773-1783. PubMed ID: 28216150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniasis.
    Mullen AB; Carter KC; Baillie AJ
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2089-92. PubMed ID: 9333030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biodistribution of amphotericin B when delivered through cholesterol hemisuccinate vesicles in normal and A. fumigatus infected mice.
    Saxena S; Ghosh PC
    Pharm Res; 2000 Oct; 17(10):1236-42. PubMed ID: 11145229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The penetration of amphotericin B from an Intralipid formulation into fibrin loci in a rabbit model of candidiasis.
    Bouley M; Tod M; Chavanet P; Petitjean O
    Biopharm Drug Dispos; 1994 Aug; 15(6):485-92. PubMed ID: 7993986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and Renal Toxicity of Monomeric Amphotericin B in Rats after a Multiple Dose Regimen.
    Kang JY; Gao J; Shin DH; Alvarez C; Zhong W; Kwon GS
    Pharm Nanotechnol; 2016; 4(1):16-23. PubMed ID: 27774409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacious topical treatment for murine cutaneous leishmaniasis with ethanolic formulations of amphotericin B.
    Frankenburg S; Glick D; Klaus S; Barenholz Y
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3092-6. PubMed ID: 9835496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-vitro and in-vivo evaluation of a new amphotericin B emulsion-based delivery system.
    Tabosa Do Egito ES; Appel M; Fessi H; Barratt G; Puisieux F; Devissaguet JP
    J Antimicrob Chemother; 1996 Sep; 38(3):485-97. PubMed ID: 8889723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aerosol delivery of amphotericin B desoxycholate (Fungizone) and liposomal amphotericin B (AmBisome): aerosol characteristics and in-vivo amphotericin B deposition in rats.
    Ruijgrok EJ; Vulto AG; Van Etten EW
    J Pharm Pharmacol; 2000 Jun; 52(6):619-27. PubMed ID: 10875537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic evaluation of free and liposome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice.
    Gondal JA; Swartz RP; Rahman A
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1544-8. PubMed ID: 2684010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concentrations in serum and distribution in tissue of free and liposomal amphotericin B in rats during continuous intralipid infusion.
    Wasan KM; Grossie VB; Lopez-Berestein G
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2224-6. PubMed ID: 7811055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study on the efficacy of AmBisome and Fungizone in a mouse model of pulmonary aspergillosis.
    Takemoto K; Yamamoto Y; Ueda Y; Sumita Y; Yoshida K; Niki Y
    J Antimicrob Chemother; 2006 Apr; 57(4):724-31. PubMed ID: 16446374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of interleukin-1beta, tumour necrosis factor-alpha and apoptosis in mouse organs by amphotericin B is neutralized by conjugation with arabinogalactan.
    Falk R; Hacham M; Nyska A; Foley JF; Domb AJ; Polacheck I
    J Antimicrob Chemother; 2005 May; 55(5):713-20. PubMed ID: 15814605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiologically based pharmacokinetic model of amphotericin B disposition in rats following administration of deoxycholate formulation (Fungizone®): pooled analysis of published data.
    Kagan L; Gershkovich P; Wasan KM; Mager DE
    AAPS J; 2011 Jun; 13(2):255-64. PubMed ID: 21431453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.